Infection Medicine, Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.
Centre for Cardiovascular Science, University of Edinburgh, The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.
Biosens Bioelectron. 2022 Sep 15;212:114404. doi: 10.1016/j.bios.2022.114404. Epub 2022 May 20.
This study presents a new strategy and level of mechanistic understanding for ultrasensitive detection of short, non-coding RNAs without target amplification or chemical modification using electrochemical biosensors. Electrochemical impedance spectroscopy (EIS) has been used for probe target interaction detection because of its high utility for sensitive and label-free measurements of the nucleic acid targets as a result of hybridisation. EIS measurements of different probe target combinations in a range of spatial orientations and sequence overlaps showed that bringing the target overhangs closer to the nanometer proximity of the electrode surface improved the EIS signal significantly. Systematic investigations using different lengths of overhangs towards the electrode surface revealed proportionally higher EIS signals with increasing lengths of the overhangs. Our observations could be explained using the Poisson-Boltzmann and Gouy-Chapman model and followed our experimental modelling. In conclusion, the optimized arrangements of our EIS biosensor system enabled us to detect microRNA-122, a known biomarker for liver injury, as well as three common isoforms to a 1 nM (equivalent to 80 fmole) detection limit. This will enable us to develop solutions for the detection of this important blood biomarker at point of care.
本研究提出了一种新的策略和机制理解水平,用于在无需靶标扩增或化学修饰的情况下,使用电化学生物传感器对短的、非编码 RNA 进行超灵敏检测。电化学阻抗谱 (EIS) 已被用于探针靶标相互作用检测,因为它非常适合于通过杂交对核酸靶标进行灵敏和无标记的测量。不同探针靶标组合在不同空间取向和序列重叠的 EIS 测量表明,将靶标突出端拉近纳米级电极表面可以显著提高 EIS 信号。使用不同长度的突出端朝向电极表面的系统研究表明,随着突出端长度的增加,EIS 信号呈比例增加。我们的观察结果可以用泊松-玻尔兹曼和古依-查普曼模型来解释,并遵循我们的实验模型。总之,我们的 EIS 生物传感器系统的优化布置使我们能够以 1 nM(相当于 80 fmole)的检测限检测到已知的肝损伤生物标志物 microRNA-122 以及三种常见的同工型。这将使我们能够开发在护理点检测这种重要血液生物标志物的解决方案。